Search filters

List of works by Tibor Keler

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

scientific article

Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

scientific article published on 23 March 2016

Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy

article

Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy

scientific article published on 25 May 2020

Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply

scientific article published in December 2017

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

scientific article

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

scientific article published on 22 August 2017

Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma

scientific article published on 29 May 2020

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

scientific article published on 08 April 2015